{"id":13307,"date":"2014-01-01T10:24:22","date_gmt":"2014-01-01T15:24:22","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=13307"},"modified":"2014-01-01T10:23:54","modified_gmt":"2014-01-01T15:23:54","slug":"why-is-nps-pharmaceuticals-inc-nasdaqnpsp-surging","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/why-is-nps-pharmaceuticals-inc-nasdaqnpsp-surging-13307","title":{"rendered":"Why Is NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) Surging?"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 01\/01\/2014 (wallstreetpr) &#8211;\u00a0NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) has continued soaring and in the last week it rose by an additional 10%. Year-to-date, the company\u2019s shares have climbed 225%. They got this kind of a boost mainly due to the commercial launch of NPS Pharmaceuticals, Inc (NASDAQ:NPSP)\u2019s Gattex, its orphan-drug for short bowel syndrome. The U.S Food Drug Administration approved Gattex in 2012 and the launch took place in 2013 February.<\/p>\n<p style=\"text-align: justify;\">Currently, the company is right in line to generate approximately $30-$40M in its 1<sup>st<\/sup> year in the market. A major portion of NPS Pharmaceuticals, Inc (NASDAQ:NPSP)\u2019s revenue is accounted for by the royalty payments that it receives for products that it has licensed out to Takeda Pharmaceuticals and Amgen Inc.<\/p>\n<p style=\"text-align: justify;\">The projection is that NPS Pharmaceuticals, Inc (NASDAQ:NPSP) will generate approximately $130M in its total revenue in 2013. Currently the company\u2019s\u2019 market capitalization has broken through the $3B mark. What is significant is that the in 2013, there was actually a drop in the company\u2019s sales in comparison to the same period a year ago. Analysts are saying that investors are probably looking forward to the possible FDA approval of Natpara, NPS Pharmaceuticals, Inc (NASDAQ:NPSP)\u2019s next orphan-drug which might come in 2014. This drug is used for the treatment of hypoparathyroidism. It is relevant to note the company\u2019s progress in the market.<\/p>\n<p style=\"text-align: justify;\"><b>Tuesday\u2019s trading<\/b><\/p>\n<p style=\"text-align: justify;\">In Tuesday\u2019s trading session there was a rise of 1.10% in NPS Pharmaceuticals, Inc (NASDAQ:NPSP). The shares opened at $29.90, climbed to an intraday high of $30.65 and closed at $30.36. Close to 1.25M shares were traded in the Tuesday session and the average volume of 1.68M shares got traded over a period of 30 days. The 52-week low of NPS Pharmaceuticals, Inc (NASDAQ:NPSP) shares is $7.35 while the 52-week high stands at $35.72. The company has a market capitalization of $3.10 billion.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 01\/01\/2014 (wallstreetpr) &#8211;\u00a0NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) has continued soaring and in the last week it rose by an additional 10%. Year-to-date, the company\u2019s [&hellip;]<\/p>\n","protected":false},"author":32,"featured_media":13308,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[4302,4301],"stock_ticker":[],"class_list":["post-13307","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-nasdaqnpsp","tag-nps-pharmaceuticals-inc-nasdaqnpsp","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Why Is NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) Surging? - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/why-is-nps-pharmaceuticals-inc-nasdaqnpsp-surging-13307\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Why Is NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) Surging? - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 01\/01\/2014 (wallstreetpr) &#8211;\u00a0NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) has continued soaring and in the last week it rose by an additional 10%. Year-to-date, the company\u2019s [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/why-is-nps-pharmaceuticals-inc-nasdaqnpsp-surging-13307\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-01-01T15:24:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/01\/14.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"768\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Greg Folin\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Greg Folin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/why-is-nps-pharmaceuticals-inc-nasdaqnpsp-surging-13307#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/why-is-nps-pharmaceuticals-inc-nasdaqnpsp-surging-13307\"},\"author\":{\"name\":\"Greg Folin\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e\"},\"headline\":\"Why Is NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) Surging?\",\"datePublished\":\"2014-01-01T15:24:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/why-is-nps-pharmaceuticals-inc-nasdaqnpsp-surging-13307\"},\"wordCount\":319,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/why-is-nps-pharmaceuticals-inc-nasdaqnpsp-surging-13307#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/01\/14.jpg\",\"keywords\":[\"NASDAQ:NPSP\",\"NPS Pharmaceuticals Inc. (NASDAQ:NPSP)\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/why-is-nps-pharmaceuticals-inc-nasdaqnpsp-surging-13307#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/why-is-nps-pharmaceuticals-inc-nasdaqnpsp-surging-13307\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/why-is-nps-pharmaceuticals-inc-nasdaqnpsp-surging-13307\",\"name\":\"Why Is NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) Surging? - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/why-is-nps-pharmaceuticals-inc-nasdaqnpsp-surging-13307#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/why-is-nps-pharmaceuticals-inc-nasdaqnpsp-surging-13307#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/01\/14.jpg\",\"datePublished\":\"2014-01-01T15:24:22+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/why-is-nps-pharmaceuticals-inc-nasdaqnpsp-surging-13307#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/why-is-nps-pharmaceuticals-inc-nasdaqnpsp-surging-13307\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/why-is-nps-pharmaceuticals-inc-nasdaqnpsp-surging-13307#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/01\/14.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/01\/14.jpg\",\"width\":1024,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/why-is-nps-pharmaceuticals-inc-nasdaqnpsp-surging-13307#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Why Is NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) Surging?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e\",\"name\":\"Greg Folin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg\",\"caption\":\"Greg Folin\"},\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/greg-folin\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Why Is NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) Surging? - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/why-is-nps-pharmaceuticals-inc-nasdaqnpsp-surging-13307","og_locale":"en_US","og_type":"article","og_title":"Why Is NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) Surging? - Wall Street PR","og_description":"Boston, MA 01\/01\/2014 (wallstreetpr) &#8211;\u00a0NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) has continued soaring and in the last week it rose by an additional 10%. Year-to-date, the company\u2019s [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/why-is-nps-pharmaceuticals-inc-nasdaqnpsp-surging-13307","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2014-01-01T15:24:22+00:00","og_image":[{"width":1024,"height":768,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/01\/14.jpg","type":"image\/jpeg"}],"author":"Greg Folin","twitter_misc":{"Written by":"Greg Folin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/why-is-nps-pharmaceuticals-inc-nasdaqnpsp-surging-13307#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/why-is-nps-pharmaceuticals-inc-nasdaqnpsp-surging-13307"},"author":{"name":"Greg Folin","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e"},"headline":"Why Is NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) Surging?","datePublished":"2014-01-01T15:24:22+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/why-is-nps-pharmaceuticals-inc-nasdaqnpsp-surging-13307"},"wordCount":319,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/why-is-nps-pharmaceuticals-inc-nasdaqnpsp-surging-13307#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/01\/14.jpg","keywords":["NASDAQ:NPSP","NPS Pharmaceuticals Inc. (NASDAQ:NPSP)"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/why-is-nps-pharmaceuticals-inc-nasdaqnpsp-surging-13307#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/why-is-nps-pharmaceuticals-inc-nasdaqnpsp-surging-13307","url":"https:\/\/cablemanpro.com\/wallstreetpr\/why-is-nps-pharmaceuticals-inc-nasdaqnpsp-surging-13307","name":"Why Is NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) Surging? - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/why-is-nps-pharmaceuticals-inc-nasdaqnpsp-surging-13307#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/why-is-nps-pharmaceuticals-inc-nasdaqnpsp-surging-13307#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/01\/14.jpg","datePublished":"2014-01-01T15:24:22+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/why-is-nps-pharmaceuticals-inc-nasdaqnpsp-surging-13307#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/why-is-nps-pharmaceuticals-inc-nasdaqnpsp-surging-13307"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/why-is-nps-pharmaceuticals-inc-nasdaqnpsp-surging-13307#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/01\/14.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/01\/14.jpg","width":1024,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/why-is-nps-pharmaceuticals-inc-nasdaqnpsp-surging-13307#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Why Is NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) Surging?"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e","name":"Greg Folin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg","caption":"Greg Folin"},"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/greg-folin"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/13307","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=13307"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/13307\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/13308"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=13307"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=13307"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=13307"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=13307"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}